Pharma Industry Applauds Final Push For Ratification Of Korea-U.S. FTA, Patent Linkage, Transparency, Among Benefits
This article was originally published in PharmAsia News
SEOUL - South Korean Prime Minister Kim Hwang-sik called on cabinet ministers to ratify Korea's free trade agreement with the United States during the country's National Assembly session Oct. 4
You may also be interested in...
Korean companies are lining up to launch Viagra generics even though Pfizer Inc. claims its patent is enforceable until 2014.
Nearly six years after negotiations started, the bilateral FTA between South Korea and the U.S. finally takes effect in March amid worries in Korea that it could ultimately harm generic-dependent local pharma companies.
Patent linkage provisions among key benefits for the pharmaceutical industry.